VYGR MEXC RealStocks
Own real VYGR shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-15 16:01:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Voyager Therapeutics, Inc. (VYGR) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $1.73, with a market capitalization of $107.66M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.59 to $5.48. This page covers its latest market performance, valuation, price trends and company information.
$107.66M | |
$1.70 | |
$1.74 | |
$1.59 | |
$1.70 | |
667.51K | |
762.16K | |
-- | |
$5.48 | |
$1.59 | |
-- | |
-- |
Voyager Therapeutics, Inc. (VYGR) last closed at $1.73 as of 2026-11-14 00:31:00, up 1.47% ($0.03) from the previous close of $1.70.
During the latest regular trading session, VYGR traded between $1.59 and $1.74, with a volume of 667.51K shares. The closing price was near the upper end and near the lower end of its 52-week range.
Over the past seven days, Voyager Therapeutics, Inc. (VYGR) moved from $1.72 to $1.73, representing a gain of 0.29% ($0.01).
The stock traded between $1.59 and $2.04 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.
The average daily volume was 1.07 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 3.6%
VYGR is currently trading at $1.73, placing it 3.6% of the way from its 52-week low of $1.59 to its 52-week high of $5.48. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 141 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Voyager Therapeutics, Inc. (VYGR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to VYGR, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between VYGR shares and USD.
VYGR Shares to USD
1.00 VYGR shares = 1.725 USD
Calculations are estimates based on the latest available price and are for reference only.